RE: Meta-analysis of the efficacy and safety of mirabegron and solifenacin monotherapy for overactive bladder

被引：0
|
作者：
Zhou, Zhongbao [1 ,2 ]
Gao, Zhenli [2 ]
机构：
[1] Binzhou Med Univ, Yantai, Shandong, Peoples R China
[2] Qingdao Univ, Affiliated Yantai Yuhuangding Hosp, Dept Urol, 20 East Yuhuangding Rd, Yantai 264000, Shandong, Peoples R China
来源：
NEUROUROLOGY AND URODYNAMICS | 2019年 / 38卷 / 06期
关键词：
D O I：
10.1002/nau.24049
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1792 / 1792
页数：1
相关论文
共 50 条
  • [1] Meta-analysis of the efficacy and safety of mirabegron and solifenacin monotherapy for overactive bladder
    Wang, Jipeng
    Zhou, Zhongbao
    Cui, Yuanshan
    Li, Yongwei
    Yuan, Hejia
    Gao, Zhenli
    Zhu, Zhe
    Wu, Jitao
    NEUROUROLOGY AND URODYNAMICS, 2019, 38 (01) : 22 - 30
  • [2] Meta-analysis of efficacy and safety of Mirabegron plus Solifenacin combination therapy in comparison with Solifenacin monotherapy in overactive bladder
    Warudkar, S.
    Jain, A. B.
    Dave, N. S.
    Chaturvedi, A. R.
    EUROPEAN UROLOGY, 2022, 81 : S662 - S663
  • [3] Meta-Analysis of the Efficacy and Safety of Mirabegron Add-On Therapy to Solifenacin for Overactive Bladder
    Xu, Yankai
    Liu, Ruihua
    Liu, Chu
    Cui, Yuanshan
    Gao, Zhenli
    INTERNATIONAL NEUROUROLOGY JOURNAL, 2017, 21 (03) : 212 - 219
  • [4] Efficacy and safety of combinations of mirabegron and solifenacin in patients with overactive bladder: a systematic review and meta-analysis
    Peng, Liao
    Zeng, Xiao
    Shen, Hong
    Luo, De-Yi
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (02): : 1355 - 1365
  • [5] Re: Efficacy and Safety of Combinations of Mirabegron and Solifenacin Compared with Monotherapy and Placebo in Patients with Overactive Bladder (SYNERGY Study)
    不详
    JOURNAL OF UROLOGY, 2018, 200 (03): : 502 - 502
  • [6] Efficacy and safety of combinations of mirabegron and solifenacin compared with monotherapy and placebo in patients with overactive bladder (SYNERGY study)
    Herschorn, Sender
    Chapple, Christopher R.
    Abrams, Paul
    Arlandis, Salvador
    Mitcheson, David
    Lee, Kyu-Sung
    Ridder, Arwin
    Stoelzel, Matthias
    Paireddy, Asha
    van Maanen, Rob
    Robinson, Dudley
    BJU INTERNATIONAL, 2017, 120 (04) : 562 - 575
  • [7] Efficacy and safety of solifenacin for overactive bladder: An updated systematic review and meta-analysis
    Ananda, I. Gede Yogi Prema
    Surya, Radika Naufal Hadi
    Surya, Prima Ardiansah
    Putratama, Alfin
    Andhika, Dimas Panca
    UROLOGY ANNALS, 2025, 17 (01) : 2 - 8
  • [8] Comparisons of Therapeutic Efficacy and Safety of Solifenacin versus Tolterodine in Patients with Overactive Bladder: A Meta-Analysis
    Wang, Hai-Tao
    Xia, Ming
    UROLOGIA INTERNATIONALIS, 2019, 103 (02) : 187 - 194
  • [9] Efficacy and safety of vibegron compared with mirabegron for overactive bladder: A systematic review and network meta-analysis
    He, Wenjuan
    Zhang, Yuqian
    Huang, Guangliang
    Tian, Yunfei
    Sun, Qian
    Liu, Xiuju
    LUTS-LOWER URINARY TRACT SYMPTOMS, 2023, 15 (03) : 80 - 88
  • [10] Long-term safety and efficacy of mirabegron and solifenacin in combination compared with monotherapy in patients with overactive bladder: SYNERGY II study
    Alcantara Montero, A.
    ACTAS UROLOGICAS ESPANOLAS, 2019, 43 (01): : 51 - 52
12345